Antagonists of growth hormone-releasing hormone (GH-RH) reduced prostate size in experimental BPH46, and we previously showed that potent synthetic antagonists of GH-RH strongly inhibit the growth of diverse experimental human tumors including prostate cancer by suppressing various tumoral growth factors47,48. This evidence concerns the gene GHRH and prostate carcinoma.